

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb40457</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>The Effect of Silver Nanoparticles on Pyocyanin Production of Pseudomonas aeruginosa Isolated From Clinical Specimens</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Najafi</surname><given-names>Mahboobeh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Nakhaei Moghaddam</surname><given-names>Mahboobeh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Yousefi</surname><given-names>Ehsan</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>13</volume>
      <issue>2</issue>
      <fpage>98</fpage>
      <lpage>103</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>6</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>11</month>
          <year>2020</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Background:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; &lt;em&gt;Pseudomonas aeruginosa (P. aeruginosa)&lt;/em&gt; is an opportunistic pathogen causing a wide range of human infections. The organism is resistant to a wide range of antibiotics. The purpose of this study was to investigate the effect of AgNPs on pyocyanin pigment production of &lt;em&gt;P. aeruginosa&lt;/em&gt; bacteria isolated from clinical specimens.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Methods:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; In this study, 15 clinical isolates of &lt;em&gt;P. aeruginosa&lt;/em&gt; were collected from different specimens of hospitalized patients. &lt;em&gt;P. aeruginosa&lt;/em&gt; was detected by biochemical and molecular (detection of pbo1 gene by colony PCR method) methods and the MIC and MBC of AgNPs were determined by agar dilution method. Inhibition of &lt;em&gt;P. aeruginosa&lt;/em&gt; pyocyanin production at AgNPs concentrations of 0, 0.3, 0.5, 1 and 1.5 &lt;em&gt;mg/ml&lt;/em&gt; of was studied with OD of 520 &lt;em&gt;nm&lt;/em&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Results:&lt;/span&gt;&lt;span style=&quot;font-size:10.0pt&quot;&gt; The mean MIC and MBC of AgNPs were 1.229 and 1.687 &lt;em&gt;mg/ml&lt;/em&gt;, respectively. Pyocyanin production was investigated for all isolates at different concentrations of nanoparticles, and their comparison showed that with increasing nanoparticle concentration, pyocyanin production significantly decreased (p&amp;lt;0.05).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;span style=&quot;font-size:9.5pt&quot;&gt;Conclusion:&lt;/span&gt; &lt;span style=&quot;font-size:10.0pt&quot;&gt;According to the results of this study, AgNPs had an inhibitory effect on &lt;em&gt;P. aeruginosa&lt;/em&gt; and its pigment production and with increasing nanoparticles concentration, pigment production decreased; therefore, it seems that the nanoparticles can be used to treat and prevent diseases caused by &lt;em&gt;P. aeruginosa&lt;/em&gt;.&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
